CUFinder

Michael Ehrenstein

About Michael Ehrenstein

Michael Ehrenstein, With an exceptional h-index of 62 and a recent h-index of 37 (since 2020), a distinguished researcher at University College London, specializes in the field of Lupus, B cells, precision medicine, rheumatology, regulatory T cells.

His recent articles reflect a diverse array of research interests and contributions to the field:

Differences in management approaches for lupus nephritis within the UK

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven …

Predictors of BILAG-based outcomes in patients with SLE: Analysis from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

SLE is not a one-size-fits-all disease

OA20 Differences in management approaches for lupus nephritis within the UK

P142 Cytomegalovirus seropositivity is associated with an increased frequency of highly differentiated T effector memory cells re-expressing CD45RA (Temra) and persistent …

OA25 Identification of biomarkers to stratify response to combination therapy with belimumab and rituximab in a randomized trial, BEAT-LUPUS for systemic lupus erythematosus

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease

Michael Ehrenstein Information

University

Position

___

Citations(all)

19897

Citations(since 2020)

4958

Cited By

17234

hIndex(all)

62

hIndex(since 2020)

37

i10Index(all)

106

i10Index(since 2020)

67

Email

University Profile Page

Google Scholar

Michael Ehrenstein Skills & Research Interests

Lupus

B cells

precision medicine

rheumatology

regulatory T cells

Top articles of Michael Ehrenstein

Differences in management approaches for lupus nephritis within the UK

Rheumatology Advances in Practice

2024/2/9

Sara T Ibrahim
Sara T Ibrahim

H-Index: 1

David Jayne
David Jayne

H-Index: 38

Liz Lightstone
Liz Lightstone

H-Index: 27

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven …

The Lancet Rheumatology

2023/11/1

Alessandra Nerviani
Alessandra Nerviani

H-Index: 15

Michele Bombardieri
Michele Bombardieri

H-Index: 40

Andrew Filer
Andrew Filer

H-Index: 43

Ernest Choy
Ernest Choy

H-Index: 60

Maya H Buch
Maya H Buch

H-Index: 35

Elisa Gremese
Elisa Gremese

H-Index: 34

Pauline Ho
Pauline Ho

H-Index: 1

Bhaskar Dasgupta
Bhaskar Dasgupta

H-Index: 8

James Galloway
James Galloway

H-Index: 26

Hector Chinoy
Hector Chinoy

H-Index: 31

Peter Sasieni
Peter Sasieni

H-Index: 43

Costantino Pitzalis
Costantino Pitzalis

H-Index: 50

Chris Buckley
Chris Buckley

H-Index: 23

Simone Perniola
Simone Perniola

H-Index: 8

Stefano Alivernini
Stefano Alivernini

H-Index: 19

Stephen Kelly
Stephen Kelly

H-Index: 6

Predictors of BILAG-based outcomes in patients with SLE: Analysis from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Lupus

2023/8

Li Su
Li Su

H-Index: 4

Benjamin Parker
Benjamin Parker

H-Index: 1

Sang-Cheol Bae
Sang-Cheol Bae

H-Index: 58

Anisur Rahman
Anisur Rahman

H-Index: 2

Murat Inanc
Murat Inanc

H-Index: 38

Anca Askanase
Anca Askanase

H-Index: 26

Mark Lunt
Mark Lunt

H-Index: 52

Niels Peek
Niels Peek

H-Index: 31

Nophar Geifman
Nophar Geifman

H-Index: 12

Sean Gavan
Sean Gavan

H-Index: 4

Patrick Doherty
Patrick Doherty

H-Index: 19

Lauren Hewitt
Lauren Hewitt

H-Index: 13

Neil Mchugh
Neil Mchugh

H-Index: 12

John Reynolds
John Reynolds

H-Index: 2

Stephen Young
Stephen Young

H-Index: 11

David Jayne
David Jayne

H-Index: 38

Matthew Pickering
Matthew Pickering

H-Index: 4

Miriam Wittmann
Miriam Wittmann

H-Index: 27

Paul Emery
Paul Emery

H-Index: 102

Michael Ehrenstein
Michael Ehrenstein

H-Index: 38

SLE is not a one-size-fits-all disease

The Journal of Experimental Medicine

2023/6/6

OA20 Differences in management approaches for lupus nephritis within the UK

Rheumatology

2023/4/1

Sara T Ibrahim
Sara T Ibrahim

H-Index: 1

David Jayne
David Jayne

H-Index: 38

Liz Lightstone
Liz Lightstone

H-Index: 27

P142 Cytomegalovirus seropositivity is associated with an increased frequency of highly differentiated T effector memory cells re-expressing CD45RA (Temra) and persistent …

Rheumatology

2023/4/1

Michael Ehrenstein
Michael Ehrenstein

H-Index: 38

OA25 Identification of biomarkers to stratify response to combination therapy with belimumab and rituximab in a randomized trial, BEAT-LUPUS for systemic lupus erythematosus

Rheumatology

2023/4/1

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease

BMC medicine

2023/2/14

Ernest Choy
Ernest Choy

H-Index: 60

Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial

The Lancet Rheumatology

2023/1/1

Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases

Value in health

2023/1/1

Ian Bruce
Ian Bruce

H-Index: 55

Mark Lunt
Mark Lunt

H-Index: 52

Niels Peek
Niels Peek

H-Index: 31

Nophar Geifman
Nophar Geifman

H-Index: 12

Sean Gavan
Sean Gavan

H-Index: 4

Patrick Doherty
Patrick Doherty

H-Index: 19

Lauren Hewitt
Lauren Hewitt

H-Index: 13

Neil Mchugh
Neil Mchugh

H-Index: 12

John Reynolds
John Reynolds

H-Index: 2

Stephen Young
Stephen Young

H-Index: 11

David Jayne
David Jayne

H-Index: 38

Li Su
Li Su

H-Index: 4

Matthew Pickering
Matthew Pickering

H-Index: 4

Miriam Wittmann
Miriam Wittmann

H-Index: 27

Paul Emery
Paul Emery

H-Index: 102

Michael Ehrenstein
Michael Ehrenstein

H-Index: 38

Richard Watts
Richard Watts

H-Index: 29

Jonathan Marks
Jonathan Marks

H-Index: 19

Mohamed Akil
Mohamed Akil

H-Index: 9

Bhaskar Dasgupta
Bhaskar Dasgupta

H-Index: 8

Christopher Edwards
Christopher Edwards

H-Index: 4

Joanna C Robson
Joanna C Robson

H-Index: 16

AB0434 EFFICACY AND SAFETY OF OBINUTUZUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH SECONDARY NON-RESPONSE TO RITUXIMAB.

2022/6/1

OP0237 DISTINCT IMMUNE NETWORKS STRATIFY ORGAN INVOLVEMENT AND RESPONSE TO B CELL TARGETED THERAPIES IN SYSTEMIC LUPUS ERYTHEMATOSUS

2022/6/1

OP0011 HIGHLY DIFFERENTIATED CD4 AND CD8 T EFFECTOR MEMORY CELLS RE-EXPRESSING CD45RA (TEMRA) ARE ASSOCIATED WITH ACTIVE DISEASE REFRACTORY TO ANTI-TNF THERAPY IN RHEUMATOID …

2022/6/1

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Scientific data

2022/5/9

P282 ANA seroconversion during prior anti-TNF therapy abolishes anti-CCP antibody positivity as a predictor of abatacept retention in rheumatoid arthritis

Rheumatology

2022/5/1

Michael Ehrenstein
Michael Ehrenstein

H-Index: 38

P241 Efficacy of obinutuzumab in systemic lupus erythematosus patients with secondary non response to rituximab

Rheumatology

2022/5/1

Michael Ehrenstein
Michael Ehrenstein

H-Index: 38

A novel Streptococcus pneumoniae human challenge model demonstrates Treg lymphocyte recruitment to the infection site

Scientific reports

2022/3/7

Helina Marshall
Helina Marshall

H-Index: 6

Impact of a mid‐urethral synthetic mesh sling on long‐term risk of systemic conditions in women with stress urinary incontinence: a national cohort study

BJOG: An International Journal of Obstetrics & Gynaecology

2022/3

The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume

Rheumatology

2022/2/1

Beating B Cells in Lupus Nephritis

Portuguese Journal of Nephrology and Hypertension

2022

Liliana Santos
Liliana Santos

H-Index: 9

José Lopes
José Lopes

H-Index: 9

Michael Ehrenstein
Michael Ehrenstein

H-Index: 38

See List of Professors in Michael Ehrenstein University(University College London)